文献速递乳房整形与再造

直接植入法在65岁及以上患者中是一种成本效益更高的选择

Direct-to-implant reconstruction as a cost-efficient option in patients aged 65 years and older.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-09-17

该单中心回顾性研究纳入2009至2023年65岁及以上接受假体乳房重建的患者,按1:2匹配直接植入与两阶段组织扩张器重建。结果显示直接植入组总成本更低、手术时间更短,且并发症风险无差异,支持其作为老年患者资源消耗更低的合理选择。

要点

  • 在≥65岁患者中,直接植入法较两阶段组织扩张器重建成本更低。
  • 直接植入法手术时间显著缩短,且不增加并发症风险。
  • 直接植入法可作为老年患者资源消耗更低的乳房重建选项。

核心结论

  • 直接植入法乳房重建与更低成本和更短手术时间相关,且未增加并发症风险。

研究设计与样本

  • 单中心回顾性研究,纳入2009至2023年≥65岁接受假体乳房重建的患者,按1:2(直接植入:组织扩张器)使用马氏距离匹配年龄、体重指数及吸烟、放疗、化疗、糖尿病和高血压病史。

主要发现

  • 匹配队列包括30例直接植入和58例组织扩张器患者。
  • 直接植入组总成本为12379±5749美元,组织扩张器组为16653±6859美元(p=0.003)。
  • 直接植入组手术时间为201±100分钟,组织扩张器组为353±115分钟(p<0.001)。
  • 校正后直接植入仍与低15%的成本相关(p=0.03),归因于手术室时间缩短36%(p<0.001)。
  • 任何并发症的比值比无差异(p=0.22)。

临床怎么用

  • 对于65岁及以上适合假体乳房重建的患者,可考虑直接植入法以降低资源消耗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Direct-to-implant (DTI) is a single-stage breast reconstruction technique. Data support its use in older patients, but most studies have focused on surgical outcomes rather than resource use. We compared costs, resource use, and outcomes between single-stage DTI and two-stage tissue expander (TE) reconstruction in patients aged ≥65 years. METHODS: A single-center retrospective review included patients ≥65 years who underwent implant-based breast reconstruction (2009-2023). Patients were matched 1:2 (DTI:TE) using Mahalanobis distance on age, body mass index, and history of smoking, radiation, chemotherapy, diabetes, and hypertension. Total cost was the sum of hospital costs spanning the index operation to one year after the final planned reconstruction, including costs for operative time, surgical materials, length of stay, emergency room visits, readmissions, and reoperations. Outcomes were analyzed using cluster-robust gamma regression with a log link and logistic regression adjusting for implant plane, laterality, and baseline characteristics. RESULTS: The matched cohort included 30 DTI and 58 TE patients. DTI was associated with lower costs ($12,379 ± $5749 vs. $16,653 ± $6859; p=0.003) and shorter operative time (201 ± 100 vs. 353 ± 115 min; p<0.001). After adjustment, DTI continued to be associated with 15% lower costs (p=0.03), driven by a 36% shorter operating room time (p<0.001). The odds of any complication did not differ (p=0.22) CONCLUSION: DTI reconstruction was associated with lower costs and shorter operative time without increased risk of complications, supporting DTI as a reasonable lower-resource option for older patients.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. MacDonald MM, Sharma S, Oral KT, et al. Direct-to-implant reconstruction as a cost-efficient option in patients aged 65 years and older. J Plast Reconstr Aesthet Surg. 2026. PMID: 42810312. doi:10.1016/j.bjps.2026.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。